40.49 USD
+1.22 (+3.11%)
At close: Feb 2, 2026
40.8074 USD
+0.32 (+0.78%)
Pre-Market: 2/3/2026, 8:40:24 AM
Taking everything into account, BTSG scores 4 out of 10 in our fundamental rating. BTSG was compared to 102 industry peers in the Health Care Providers & Services industry. BTSG has an average financial health and profitability rating. BTSG is not priced too expensively while it is growing strongly. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
- In the past year BTSG was profitable.
- BTSG had a positive operating cash flow in the past year.
- In multiple years BTSG reported negative net income over the last 5 years.
- BTSG had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- BTSG has a Return On Assets (2.14%) which is comparable to the rest of the industry.
- BTSG has a Return On Equity of 7.13%. This is in the better half of the industry: BTSG outperforms 64.71% of its industry peers.
- BTSG's Return On Invested Capital of 4.68% is in line compared to the rest of the industry. BTSG outperforms 54.90% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for BTSG is significantly below the industry average of 9.16%.
- The 3 year average ROIC (3.45%) for BTSG is below the current ROIC(4.68%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.14% | ||
| ROE | 7.13% | ||
| ROIC | 4.68% |
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
1.3 Margins
- BTSG has a Profit Margin (1.04%) which is comparable to the rest of the industry.
- With a Operating Margin value of 2.15%, BTSG perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
- In the last couple of years the Operating Margin of BTSG has grown nicely.
- BTSG has a worse Gross Margin (12.30%) than 68.63% of its industry peers.
- BTSG's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.15% | ||
| PM (TTM) | 1.04% | ||
| GM | 12.3% |
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BTSG is destroying value.
- The number of shares outstanding for BTSG has been increased compared to 1 year ago.
- Compared to 5 years ago, BTSG has more shares outstanding
- Compared to 1 year ago, BTSG has an improved debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 3.45 indicates that BTSG is not in any danger for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 3.45, BTSG is in the better half of the industry, outperforming 71.57% of the companies in the same industry.
- The Debt to FCF ratio of BTSG is 9.17, which is on the high side as it means it would take BTSG, 9.17 years of fcf income to pay off all of its debts.
- BTSG has a Debt to FCF ratio (9.17) which is in line with its industry peers.
- A Debt/Equity ratio of 1.36 is on the high side and indicates that BTSG has dependencies on debt financing.
- BTSG has a worse Debt to Equity ratio (1.36) than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.36 | ||
| Debt/FCF | 9.17 | ||
| Altman-Z | 3.45 |
ROIC/WACC0.52
WACC9%
2.3 Liquidity
- A Current Ratio of 1.79 indicates that BTSG should not have too much problems paying its short term obligations.
- BTSG's Current ratio of 1.79 is fine compared to the rest of the industry. BTSG outperforms 70.59% of its industry peers.
- A Quick Ratio of 1.38 indicates that BTSG should not have too much problems paying its short term obligations.
- BTSG has a Quick ratio (1.38) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 117.02% over the past year.
- The Revenue has grown by 17.23% in the past year. This is quite good.
- Measured over the past years, BTSG shows a very strong growth in Revenue. The Revenue has been growing by 20.01% on average per year.
EPS 1Y (TTM)117.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%254.55%
Revenue 1Y (TTM)17.23%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%14.7%
3.2 Future
- Based on estimates for the next years, BTSG will show a very strong growth in Earnings Per Share. The EPS will grow by 43.45% on average per year.
- The Revenue is expected to grow by 15.41% on average over the next years. This is quite good.
EPS Next Y97.42%
EPS Next 2Y57.66%
EPS Next 3Y45%
EPS Next 5Y43.45%
Revenue Next Year13.42%
Revenue Next 2Y14.12%
Revenue Next 3Y13.85%
Revenue Next 5Y15.41%
3.3 Evolution
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 39.70 indicates a quite expensive valuation of BTSG.
- BTSG's Price/Earnings is on the same level as the industry average.
- When comparing the Price/Earnings ratio of BTSG to the average of the S&P500 Index (28.41), we can say BTSG is valued slightly more expensively.
- Based on the Price/Forward Earnings ratio of 29.62, the valuation of BTSG can be described as expensive.
- BTSG's Price/Forward Earnings ratio is in line with the industry average.
- BTSG is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 25.64, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.7 | ||
| Fwd PE | 29.62 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BTSG is on the same level as its industry peers.
- BTSG's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 26.45 | ||
| EV/EBITDA | 21.74 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as BTSG's earnings are expected to grow with 45.00% in the coming years.
PEG (NY)0.41
PEG (5Y)N/A
EPS Next 2Y57.66%
EPS Next 3Y45%
5. Dividend
5.1 Amount
- BTSG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
40.49
+1.22 (+3.11%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-20 2025-10-20/amc
Earnings (Next)02-26 2026-02-26/bmo
Inst Owners73.18%
Inst Owner Change0.37%
Ins Owners2.49%
Ins Owner Change-8.66%
Market Cap7.30B
Revenue(TTM)12.41B
Net Income(TTM)129.59M
Analysts86.36
Price Target42.16 (4.12%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.94%
Min EPS beat(2)26.26%
Max EPS beat(2)41.61%
EPS beat(4)3
Avg EPS beat(4)40.55%
Min EPS beat(4)-2.7%
Max EPS beat(4)97.01%
EPS beat(8)5
Avg EPS beat(8)26.15%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.23%
Min Revenue beat(2)3.22%
Max Revenue beat(2)3.24%
Revenue beat(4)3
Avg Revenue beat(4)2.17%
Min Revenue beat(4)-0.62%
Max Revenue beat(4)3.24%
Revenue beat(8)6
Avg Revenue beat(8)2.96%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.65%
PT rev (3m)27.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)9.65%
EPS NY rev (1m)0%
EPS NY rev (3m)5.87%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.25%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.75%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.7 | ||
| Fwd PE | 29.62 | ||
| P/S | 0.59 | ||
| P/FCF | 26.45 | ||
| P/OCF | 20.91 | ||
| P/B | 4.02 | ||
| P/tB | N/A | ||
| EV/EBITDA | 21.74 |
EPS(TTM)1.02
EY2.52%
EPS(NY)1.37
Fwd EY3.38%
FCF(TTM)1.53
FCFY3.78%
OCF(TTM)1.94
OCFY4.78%
SpS68.83
BVpS10.08
TBVpS-5.95
PEG (NY)0.41
PEG (5Y)N/A
Graham Number15.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.14% | ||
| ROE | 7.13% | ||
| ROCE | 5.92% | ||
| ROIC | 4.68% | ||
| ROICexc | 4.83% | ||
| ROICexgc | 14.34% | ||
| OM | 2.15% | ||
| PM (TTM) | 1.04% | ||
| GM | 12.3% | ||
| FCFM | 2.22% |
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
ROICexc(3y)3.47%
ROICexc(5y)3.63%
ROICexgc(3y)17.05%
ROICexgc(5y)18.21%
ROCE(3y)4.37%
ROCE(5y)4.5%
ROICexgc growth 3Y-9.4%
ROICexgc growth 5Y19.06%
ROICexc growth 3Y-3.14%
ROICexc growth 5Y18.48%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
F-Score7
Asset Turnover2.05
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.36 | ||
| Debt/FCF | 9.17 | ||
| Debt/EBITDA | 5.55 | ||
| Cap/Depr | 40.71% | ||
| Cap/Sales | 0.59% | ||
| Interest Coverage | 1.44 | ||
| Cash Conversion | 78.31% | ||
| Profit Quality | 213.06% | ||
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 3.45 |
F-Score7
WACC9%
ROIC/WACC0.52
Cap/Depr(3y)36.76%
Cap/Depr(5y)33.73%
Cap/Sales(3y)0.82%
Cap/Sales(5y)0.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)117.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%254.55%
EPS Next Y97.42%
EPS Next 2Y57.66%
EPS Next 3Y45%
EPS Next 5Y43.45%
Revenue 1Y (TTM)17.23%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%14.7%
Revenue Next Year13.42%
Revenue Next 2Y14.12%
Revenue Next 3Y13.85%
Revenue Next 5Y15.41%
EBIT growth 1Y36.15%
EBIT growth 3Y-4.13%
EBIT growth 5Y26.66%
EBIT Next Year63.58%
EBIT Next 3Y29.11%
EBIT Next 5Y28.14%
FCF growth 1Y324.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y820.28%
OCF growth 3Y-55.52%
OCF growth 5Y-26.51%
BRIGHTSPRING HEALTH SERVICES / BTSG FAQ
Can you provide the ChartMill fundamental rating for BRIGHTSPRING HEALTH SERVICES?
ChartMill assigns a fundamental rating of 4 / 10 to BTSG.
Can you provide the valuation status for BRIGHTSPRING HEALTH SERVICES?
ChartMill assigns a valuation rating of 4 / 10 to BRIGHTSPRING HEALTH SERVICES (BTSG). This can be considered as Fairly Valued.
How profitable is BRIGHTSPRING HEALTH SERVICES (BTSG) stock?
BRIGHTSPRING HEALTH SERVICES (BTSG) has a profitability rating of 4 / 10.
What is the financial health of BRIGHTSPRING HEALTH SERVICES (BTSG) stock?
The financial health rating of BRIGHTSPRING HEALTH SERVICES (BTSG) is 4 / 10.
What is the earnings growth outlook for BRIGHTSPRING HEALTH SERVICES?
The Earnings per Share (EPS) of BRIGHTSPRING HEALTH SERVICES (BTSG) is expected to grow by 97.42% in the next year.